06/14/2024
5:15 PM | Congleton Jon (Reporting)
Mineralys Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2024
3:56 PM | Congleton Jon (Reporting)
Mineralys Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/14/2024
7:06 AM | Mineralys Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/13/2024
4:32 PM | Mineralys Therapeutics (Issuer)
Rodman David Malcom (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2024
4:33 PM | Levy Adam Scott (Reporting)
Mineralys Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2024
3:51 PM | Congleton Jon (Reporting)
Mineralys Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/12/2024
4:56 PM | Congleton Jon (Reporting)
Mineralys Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
|
06/11/2024
3:50 PM | Levy Adam Scott (Reporting)
Mineralys Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/28/2024
5:51 PM | Kolchinsky Peter (Reporting)
Mineralys Therapeutics (Issuer)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, L.P. (Reporting)
RA Capital Nexus Fund III, L.P. (Reporting)
Shah Rajeev M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/22/2024
3:38 PM | Mineralys Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/15/2024
3:43 PM | Mineralys Therapeutics (Issuer)
Rodman David Malcom (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/09/2024
4:14 PM | Mineralys Therapeutics (Subject)
Rodman David Malcom (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/09/2024
6:07 AM | Mineralys Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/09/2024
6:10 AM | Mineralys Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/15/2024
3:24 PM | Mineralys Therapeutics (Issuer)
Rodman David Malcom (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/11/2024
11:15 PM | Mineralys Therapeutics (Filer)
| Form EFFECT | |
04/11/2024
3:35 PM | Mineralys Therapeutics (Filer)
| Form 424B5 | |
04/09/2024
6:15 AM | Mineralys Therapeutics (Filer)
| Form DEF 14A | |
04/09/2024
6:18 AM | Mineralys Therapeutics (Filer)
| Form DEFA14A | |
04/09/2024
6:21 AM | Mineralys Therapeutics (Filer)
| Form ARS | |
04/04/2024
7:04 AM | Mineralys Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/29/2024
3:44 PM | Mineralys Therapeutics (Filer)
| Form S-3/A | |
03/21/2024
6:43 AM | Mineralys Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/21/2024
6:30 AM | Mineralys Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
03/21/2024
6:14 AM | Mineralys Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/13/2024
4:35 PM | Mineralys Therapeutics (Issuer)
Rodman David Malcom (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/15/2024
3:20 PM | Mineralys Therapeutics (Subject)
TCG Crossover GP II, LLC (Filed by)
| Form SC 13G | |
02/14/2024
8:06 PM | Mineralys Therapeutics (Issuer)
Samsara BioCapital GP, LLC (Reporting)
Samsara BioCapital, L.P. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
8:07 PM | AKKARAJU SRINIVAS (Reporting)
Mineralys Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
6:49 PM | Kolchinsky Peter (Reporting)
Mineralys Therapeutics (Issuer)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, L.P. (Reporting)
RA Capital Nexus Fund III, L.P. (Reporting)
Shah Rajeev M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
5:04 AM | ADAMS STREET PARTNERS LLC (Filed by)
Mineralys Therapeutics (Subject)
| Form SC 13G | |
02/08/2024
3:41 PM | Mineralys Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/12/2024
3:01 PM | Mineralys Therapeutics (Issuer)
Rodman David Malcom (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/22/2023
8:04 AM | Mineralys Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2023
5:18 PM | Mineralys Therapeutics (Issuer)
Rodman David Malcom (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/13/2023
7:20 AM | Mineralys Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/07/2023
4:15 PM | Mineralys Therapeutics (Issuer)
Rodman David Malcom (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/02/2023
9:06 AM | Mineralys Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/14/2023
3:11 PM | Mineralys Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/14/2023
3:13 PM | Mineralys Therapeutics (Issuer)
SBLENDORIO GLENN (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
09/14/2023
3:13 PM | Mineralys Therapeutics (Issuer)
SBLENDORIO GLENN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Bigger Than NVIDIA? (Ad) With NVIDIA flying high, everyone is looking for the next breakout stock.
But right now...
There's only ONE stock you should be watching. Get the full story here >>> |
09/14/2023
3:13 PM | Karydas Daphne (Reporting)
Mineralys Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/14/2023
3:14 PM | Karydas Daphne (Reporting)
Mineralys Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
09/08/2023
7:49 AM | Congleton Jon (Reporting)
Mineralys Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/11/2023
6:11 PM | Congleton Jon (Reporting)
Mineralys Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/11/2023
6:11 PM | Mineralys Therapeutics (Issuer)
Rodman David Malcom (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/11/2023
3:55 PM | Mineralys Therapeutics (Subject)
Rodman David Malcom (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/10/2023
5:51 PM | Mineralys Therapeutics (Subject)
Rodman David Malcom (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/17/2023
3:03 PM | Mineralys Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/14/2023
7:55 AM | Catalys Pacific Fund, LP (Reporting)
Mineralys Therapeutics (Issuer)
Slingsby Brian Taylor (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/14/2023
7:55 AM | Mineralys Therapeutics (Issuer)
Takahashi Takeshi (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
